Microneedle Patch Delivery of Methotrexate-Loaded Albumin Nanoparticles to Immune Cells Achieves a Potent Antipsoriatic Effect
Huaiji Wang,Zihan Zhao,Chenghao Wu,Xiaowen Tong,Yuling Shi,Shunjie Chen
DOI: https://doi.org/10.2147/IJN.S371183
IF: 7.033
2022-09-02
International Journal of Nanomedicine
Abstract:Huaiji Wang, 1, &ast Zihan Zhao, 2, &ast Chenghao Wu, 3, &ast Xiaowen Tong, 3 Yuling Shi, 2 Shunjie Chen 1 1 Department of Nephrology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, 200443, People's Republic of China; 3 Department of Obstetrics and Gynecology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shunjie Chen, Department of Nephrology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China, Email Introduction: Transdermal drug delivery provides a desirable alternative method of penetrating the skin for psoriasis treatment, by virtue of its ability to dampen the overactivation of immune cells and inflammation, while attenuating the detrimental effects of systemic administration. Lymph nodes (LNs), as a critical organ of the lymphatic and the acquired immune system, are suitable sites for drug homing to suppress the immune cells. Methods: In this context, we developed a microneedle (MN) patch that delivers nanodrugs locally to LNs for improving the antipsoriatic treatment. In this study, human serum albumin nanoparticles carrying methotrexate (HM) were synthesized and loaded into hyaluronic acid (HA)-based microneedles (HM/MN). Results: The patch showed an excellent ability to pierce the skin, which enhanced drug delivery. In a mouse model of psoriasis, the HM/MN patch significantly prevented the erythema with decreased skin thickness, thus inhibiting the progression of psoriasis. Further analysis for immune cells in LNs, the percent of dendritic cells (DC) and T cells reduced after the local treatment with HM/MN. Notably, the feasibility of targeted delivery of methotrexate to LNs using nanoparticles was verified by detecting increased accumulation of methotrexate in LNs. In addition, the HM/MN patch pronouncedly decreased the levels of tumor necrosis factor α and interleukin 6 in the skin. Conclusion: The results suggested the high efficacy of using the HM/MN patch to treat psoriasis, and provided new insight into the mechanism of the transdermal drug delivery system. Keywords: microneedles, transdermal drug delivery, psoriasis, lymph node homing, nanodrug Psoriasis is an incurable chronic inflammatory autoimmune disease with a high recurrence rate that affects the skin, joints and nails, and whose main pathological mechanisms include immune imbalance and damaged skin barrier. 1 The etiology of psoriasis is complex, and involves T cell activation, inflammatory cell infiltration, keratinocyte hyperproliferation, etc. 2 With the advances in the understanding of the immune mechanism underlying the pathogenesis of psoriasis, therapeutics aimed at regulating the immune response have been gradually introduced for the clinical treatment of psoriasis. Methotrexate (MTX), an affordable small molecule immunosuppressant drug, can suppress the immune system, and is considered the first-line systemic drug for treating most moderate-to-severe psoriasis. 3,4 However, traditional oral administration usually leads to adverse effects, such as oral ulcers, gastrointestinal intolerance, myelosuppression and toxicity to the liver and lung. Approximately 30% of patients were discontinued from MTX treatment due to liver toxicity and lack of effective measurement to precisely predict the therapy outcome and side effects in the clinic, creating a dilemma for its wide application. 5,6 A transdermal drug delivery system for local treatment could target the diseased region of the skin, and is considered as an effective approach for the management of psoriasis, that reduces the adverse effects due to systemic administration. 7–10 However, the stratum corneum, the outermost lipophilic and dead layer of skin that acts as a first barrier to foreign substances entering the body, water leaving the body, and drug delivery, limits the transdermal penetration efficiency and reduces the bioavailability of the drug. 11 Remarkably, MN can directly pierce the stratum corneum, greatly promoting the efficiency of transdermal drug delivery. 12,13 Therefore, MN patches have been widely applied in the treatment of superficial tumors, scars, psoriasis, herpes, acne and hair loss. 14 Soluble MN have the hallmarks of a simple preparation process, low cost, large drug loading, and no needle tip w -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology